Press Releases

April 18, 2019

PharmaCielo Announces Its Financial Results for the Fourth Quarter and Fiscal Year 2018

Read more
April 9, 2019

PharmaCielo Appoints New and Extended Medical and Scientific Advisory Board

Read more
March 29, 2019

PharmaCielo Doubles Its Portfolio of Proprietary Cannabis Strains Approved for Colombia’s Cultivar Registration

Read more
March 19, 2019

PharmaCielo Receives ISO 9001 Quality Assurance Certification for Its Medicinal Cannabis Cultivation and Processing Operations in Colombia

Read more
February 6, 2019

PharmaCielo Receives Approval for Cultivar Registration of 10 Proprietary Cannabis Strains

Read more
January 28, 2019

PharmaCielo Establishes Joint Venture with Mino Labs to Bring Medicinal Cannabis Oil to Mexico

Read more
January 18, 2019

PharmaCielo Begins Trading on the TSX Venture Exchange Under Ticker PCLO

Read more
January 9, 2019

PharmaCielo Announces TSX Venture Listing and Provides Corporate Update

Read more
December 13, 2018

PharmaCielo to Produce 500-Year-Old Cannabis Strain in the Ancestral Territory of the Arhuaco

Read more
September 10, 2018

PharmaCielo Announces David Gordon as Chief Corporate Officer

Read more
Back to Company News & Media Coverage